Thermo Fisher Scientific Inc. (TMO)
| Market Cap | 161.48B |
| Revenue (ttm) | 42.90B |
| Net Income (ttm) | 6.51B |
| Shares Out | 377.49M |
| EPS (ttm) | 17.06 |
| PE Ratio | 25.08 |
| Forward PE | 18.70 |
| Dividend | $1.72 (0.41%) |
| Ex-Dividend Date | Jun 13, 2025 |
| Volume | 2,669,288 |
| Open | 425.00 |
| Previous Close | 421.47 |
| Day's Range | 421.75 - 430.46 |
| 52-Week Range | 385.46 - 627.88 |
| Beta | 0.77 |
| Analysts | Buy |
| Price Target | 595.76 (+39.27%) |
| Earnings Date | Jul 23, 2025 |
About TMO
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar... [Read more]
Financial Performance
In 2024, Thermo Fisher's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.
Financial StatementsAnalyst Summary
According to 17 analysts, the average rating for TMO stock is "Buy." The 12-month stock price target is $595.76, which is an increase of 39.27% from the latest price.
News
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 23, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2025 before...
Thermo Fisher Scientific Rises 3.1% After Key Trading Signal
TMO rose over 12 points after the alert
Xcell Biosciences Announces Joint Research Collaboration with Thermo Fisher Scientific to Advance the Next Generation of Cell Therapies
SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic collaboration wit...
Thermo Fisher Scientific Awarded $94.5 Million U.S. Government Contract to Supply the Navy with Advanced Radiation Detection Systems
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that it has been awarded a five-year, $94.5 million contract by the U.S. Department of D...
3Q Investing Outlook: Why Farmer Likes PEP, TMO, UNH
Karl Farmer says investors have to "be comfortable with short-term volatility" as the markets approach the 3Q. He's looking to any modifications coming to the Trump Administration's 90-day tariff paus...
Neurophotonics Research & Therapeutics Market 2025-2029: Global and Regional Analysis by Type and End User Featuring Carl Zeiss, Femtonics, Hitachi, Thermo Fisher Scientific and More
Dublin, June 20, 2025 (GLOBE NEWSWIRE) -- The "Neurophotonics Market 2025-2029" report has been added to ResearchAndMarkets.com's offering.
Tufts Center Study Shows Significant Time Savings in Delivering Therapies to Patients with Thermo Fisher Scientific's Accelerator™ Drug Development 360° CDMO and CRO Solutions
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the findings of new research by the Tufts Center for the Study of Drug Development ...
Report: Biotech Research Firm Thermo Fisher Considers Selling Diagnostics Business
Biotechnology research firm Thermo Fisher Scientific is reportedly looking to sell part of its diagnostics business amid industrywide concerns about federal cutbacks in spending on research.
Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms
MUNICH--(BUSINESS WIRE)--Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced a strategic collaboration with Thermo Fisher Scie...
Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports
Thermo Fisher Scientific plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported on Thursday, citing people familia...
Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to Revolutionize Biopharma Applications and Omics Research
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of the Thermo Scientific™ Orbitrap™ Astral™ Zoom mass spectr...
Thermo Fisher: With A 30% Price Drop, Trump Legislation, And High Capex, Is It Undervalued?
The neutral DCF model implemented in this article suggests that Thermo Fisher is undervalued by 29.24%. Thermo Fisher has invested, on average, 16.51% of its revenues in capex between 2019 and 2024. D...
Thermo Fisher Is Strengthening Its Long-Term Advantage
Thermo Fisher's 2025 headwinds from tariffs and US research funding cuts are real but temporary, not reflective of structural weakness in its fundamentals. The company is mitigating trade impacts by i...
So Cheap It's Silly - 2 Dividend Stocks I'd Buy Twice If I Could
Market extremes often drive flawed narratives. Many investors get spooked by sell-offs or seduced by overvaluations, when real opportunity hides in discomfort. While today's market isn't euphoric, it'...
Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased Speed, Versatility and Reliability to Labs
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today launched the spectral-enabled Invitrogen™ Attune™ Xenith™ Flow Cytometer, allowing immunology...
Thermo Fisher Scientific Stock: Big Upside Potential After Sluggishness Through November?
Thermo Fisher Scientific Inc. TMO is currently navigating a rare and telling phase in its journey through the Adhishthana Cycle. The stock is in its 18th Phase, simultaneously on both the weekly and m...
Thermo Fisher Scientific Celebrates Precision Oncology Advancement at ASCO 2025
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, will showcase some of the technologies that have helped power precision oncology at the 2025 American ...
Thermo Fisher Scientific Introduces Next Generation TruNarc Handheld Narcotics Analyzers to Support Public Safety
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today introduced the Thermo Scientific™ TruNarc™ Delta and Tau Handheld Narcotics Analyzers* to help com...
Thermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0....
Thermo Fisher Scientific Inc. (TMO) BofA Securities 2025 Healthcare Conference (Transcript)
Thermo Fisher Scientific Inc. (NYSE:TMO) BofA Securities 2025 Healthcare Conference May 13, 2025 11:40 AM ET Company Participants Marc Casper - Chairman, President & Chief Executive Officer Conferenc...
Thermo Fisher: Tariffs Hit, Valuation Compensates
The macro environment has clearly deteriorated, with tariffs and U.S. policy weighing on short-term earnings. Management revised EPS down ~$1, but revenue guidance held as pricing and FX helped offset...
10 Undervalued Dividend Growth Stocks: May 2025
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and anoth...
Thermo Fisher Scientific to Present at BofA Securities 2025 Health Care Conference on May 13
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pr...
3 Of The Cheapest High-Quality Stocks Money Can Buy
Geopolitical risks and economic uncertainty have battered markets, but I view this turmoil as an opportunity to buy high-quality, undervalued stocks. Despite volatility and weak earnings trends, I'm f...
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha...